Noble James
CIK: 0001388000
Director
Primary company: GW PHARMACEUTICALS PLC (GWPH)
Noble James is a corporate insider at GW PHARMACEUTICALS PLC (GWPH) filing SEC Form 4 transactions. 56 transactions across 5 companies, totaling $57,400 in purchases and $7,331,083 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
LAVA Therapeutics NV LVTX | Disposition | 33,390 | - | - | 0 | 11/13/2025 Filed: 11/17/2025 | Filing → |
LAVA Therapeutics NV LVTX | Award | 33,390 | $0.93 | $31K | 33,390 | 2/13/2025 Filed: 2/18/2025 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 710,711 | $0.00 | $0 | 710,711 | 7/1/2022 Filed: 7/1/2022 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 379,788 | $0.00 | $0 | 379,788 | 7/1/2021 Filed: 7/2/2021 | Filing → |
| Disposition | 22,464 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 34,416 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 9,432 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 16,548 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 10,740 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 17,676 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 9,168 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 18,636 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Disposition | 27,492 | - | - | 0 | 5/5/2021 Filed: 5/7/2021 | Filing → | |
| Award | 22,464 | $0.00 | $0 | 22,464 | 2/22/2021 Filed: 2/24/2021 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Award | 179,785 | $0.00 | $0 | 179,785 | 7/1/2020 Filed: 7/1/2020 | Filing → |
| Award | 34,416 | $0.00 | $0 | 34,416 | 6/4/2020 Filed: 6/8/2020 | Filing → | |
Adaptimmune Therapeutics PLC ADAP | Sale | 500,000 | $9.33 | $4.67M | 0 | 5/29/2020 Filed: 6/2/2020 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Award | 31,000 | $0.00 | $0 | 31,000 | 4/1/2020 Filed: 4/1/2020 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 200,000 | $5.00 | $1.00M | 0 | 1/13/2020 Filed: 1/15/2020 | Filing → |
Adaptimmune Therapeutics PLC ADAP | Sale | 100,000 | $4.00 | $400K | 0 | 1/13/2020 Filed: 1/15/2020 | Filing → |
LAVA Therapeutics NV
LVTX
Type
Disposition
Shares
33,390
Price
-
Value
-
LAVA Therapeutics NV
LVTX
Type
Award
Shares
33,390
Price
$0.93
Value
$31K
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
710,711
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
379,788
Price
$0.00
Value
$0
Type
Disposition
Shares
22,464
Price
-
Value
-
Type
Disposition
Shares
34,416
Price
-
Value
-
Type
Disposition
Shares
9,432
Price
-
Value
-
Type
Disposition
Shares
16,548
Price
-
Value
-
Type
Disposition
Shares
10,740
Price
-
Value
-
Type
Disposition
Shares
17,676
Price
-
Value
-
Type
Disposition
Shares
9,168
Price
-
Value
-
Type
Disposition
Shares
18,636
Price
-
Value
-
Type
Disposition
Shares
27,492
Price
-
Value
-
Type
Award
Shares
22,464
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
179,785
Price
$0.00
Value
$0
Type
Award
Shares
34,416
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
500,000
Price
$9.33
Value
$4.67M
Adaptimmune Therapeutics PLC
ADAP
Type
Award
Shares
31,000
Price
$0.00
Value
$0
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
200,000
Price
$5.00
Value
$1.00M
Adaptimmune Therapeutics PLC
ADAP
Type
Sale
Shares
100,000
Price
$4.00
Value
$400K
AI Agent
Try asking...